{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:38:31Z","timestamp":1785548311424,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-2-005\/N\/7\/K"],"award-info":[{"award-number":["KNW-2-005\/N\/7\/K"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-1-034\/K\/7\/O"],"award-info":[{"award-number":["KNW-1-034\/K\/7\/O"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40199-018-0206-4","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T20:46:59Z","timestamp":1532465219000},"page":"85-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro melanogenesis inhibition by fluphenazine and prochlorperazine in normal human melanocytes lightly pigmented"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-7737","authenticated-orcid":false,"given":"Micha\u0142","family":"Otr\u0119ba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Beberok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Wrze\u015bniok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Buszman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"206_CR1","first-page":"1","volume":"2","author":"M Asif","year":"2016","unstructured":"Asif M. Antipsychotic agents. Pharmacological activities of compounds containing arylpiperazines. IJCRACCE. 2016;2:1\u201330.","journal-title":"IJCRACCE"},{"key":"206_CR2","first-page":"459","volume":"23","author":"B Morak-M\u0142odawska","year":"2007","unstructured":"Morak-M\u0142odawska B, Jele\u0144 M. New biological properties of neuroleptic phenothiazines. Pol Merkur Lekarski. 2007;23:459\u201361.","journal-title":"Pol Merkur Lekarski"},{"key":"206_CR3","first-page":"53","volume":"5","author":"G Ayano","year":"2016","unstructured":"Ayano G. First generation antipsychotics. Pharmacokinetics, pharmacodynamics, therapeutic effects and side effects. A review. RRJCHEM. 2016;5:53\u201363.","journal-title":"RRJCHEM"},{"key":"206_CR4","doi-asserted-by":"publisher","unstructured":"Tardy M, Huhn M, Engel RR, Leucht S. Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia (review). Cochrane Database Syst Rev. 2014; \n                    https:\/\/doi.org\/10.1002\/14651858:CD009230\n                    \n                  .","DOI":"10.1002\/14651858:CD009230"},{"issue":"3","key":"206_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1590\/S1516-44462008000300008","volume":"30","author":"Val\u00e9ria Barreto Novais e Souza","year":"2008","unstructured":"Souza VB, Moura Filho FJ, Souza FG, Rocha CF, Furtado FA, Gon\u00e7alves TB, et al. Cataract occurrence in patients treated with antipsychotic drugs. Rev Bras Psiquiatr. 2008;30:222\u20136.","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"206_CR6","first-page":"56","volume":"18","author":"V Lamer","year":"2010","unstructured":"Lamer V, Lipozenci\u0107 J, Turci\u0107 P. Adverse cutaneous reactions to psychopharmaceuticals. Acta Dermatovenerol Croat. 2010;18:56\u201367.","journal-title":"Acta Dermatovenerol Croat"},{"key":"206_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","volume":"17","author":"RE Boissy","year":"2004","unstructured":"Boissy RE, Manga P. On the etiology of contact\/occupational vitiligo. Pigment Cell Res. 2004;17:208\u201314.","journal-title":"Pigment Cell Res"},{"key":"206_CR8","first-page":"29","volume":"17","author":"KE O'Reilly","year":"2011","unstructured":"O'Reilly KE, Patel U, Chu J, Patel R, Machler BC. Chemical leukoderma. Dermatol Online J. 2011;17:29.","journal-title":"Dermatol Online J"},{"issue":"5","key":"206_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/pcmr.12393","volume":"28","author":"Marco d'Ischia","year":"2015","unstructured":"d'Ischia M, Wakamatsu K, Cicoira F, Di Mauro E, Garcia-Borron JC, Commo S, et al. Melanins and melanogenesis: from pigment cells to human health and technological applications. Pigment Cell Melanoma Res. 2015;28:520\u201344.","journal-title":"Pigment Cell & Melanoma Research"},{"key":"206_CR10","first-page":"60","volume":"66","author":"J Rok","year":"2012","unstructured":"Rok J, Otr\u0119ba M, Buszman E, Wrze\u015bniok D. Melanin \u2013 from melanocyte to keratinocyte, that is how melanin is transported within the skin. Ann Acad Med Siles. 2012;66:60\u201366.","journal-title":"Ann Acad Med Siles"},{"key":"206_CR11","first-page":"372","volume":"63","author":"E Buszman","year":"2008","unstructured":"Buszman E, Beberok A, R\u00f3\u017ca\u0144ska R, Orzechowska A. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro. Pharmazie. 2008;63:372\u20136.","journal-title":"Pharmazie"},{"key":"206_CR12","first-page":"171","volume":"72","author":"M Otr\u0119ba","year":"2017","unstructured":"Otr\u0119ba M, Wrze\u015bniok D, Rok J, Beberok A, Buszman E. Prochlorperazine interaction with melanin and melanocytes. Die Pharmazie. 2017;72:171\u20136.","journal-title":"Die Pharmazie"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.tiv.2014.10.016","volume":"29","author":"M Otr\u0119ba","year":"2015","unstructured":"Otr\u0119ba M, Wrze\u015bniok D, Beberok A, Rok J, Buszman E. Melanogenesis and antioxidant defense system in normal human melanocytes cultured in the presence of chlorpromazine. Toxicol in Vitro. 2015;29:221\u20137.","journal-title":"Toxicol in Vitro"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00210-015-1144-z","volume":"388","author":"M Otr\u0119ba","year":"2015","unstructured":"Otr\u0119ba M, Beberok A, Wrze\u015bniok D, Rok J, Buszman E. Effect of thioridazine on antioxidant status of HEMn-DP melanocytes. Naunyn Schmiedeberg's Arch Pharmacol. 2015;388:1097\u2013104.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"206_CR15","first-page":"903","volume":"73","author":"M Otr\u0119ba","year":"2016","unstructured":"Otr\u0119ba M, Wrze\u015bniok D, Beberok A, Rok J, Buszman E. Fluphenazine and perphenazine impact on melanogenesis and antioxidant enzymes activity in normal human melanocytes. Acta Pol Pharm-Drug Res. 2016;73:903\u201311.","journal-title":"Acta Pol Pharm-Drug Res"},{"issue":"2","key":"206_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1600-0749.2006.00293.x","volume":"19","author":"Kazumasa Wakamatsu","year":"2006","unstructured":"Wakamatsu K, Kavanagh R, Kadekaro AL, Terzieva S, Sturm RA, Leachman S, et al. Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin. Pigment Cell Res. 2006;19:154\u201362.","journal-title":"Pigment Cell Research"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaap.2017.01.009","volume":"124","author":"A Dzier\u017c\u0119ga-L\u0119cznar","year":"2017","unstructured":"Dzier\u017c\u0119ga-L\u0119cznar A, Kurkiewicz S, Tam I, Marek \u0141, St\u0119pie\u0144 K. Pheomelanin content of cultured human melanocytes from lightly and darkly pigmented skin: a pyrolysis-gas chromatography\/tandem mass spectrometry study. J Anal Appl Pyrolysis. 2017;124:349\u201354.","journal-title":"J Anal Appl Pyrolysis"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","volume":"122","author":"CL Winek","year":"2001","unstructured":"Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood - level data 2001. Forensic Sci Int. 2001;122:107\u201323.","journal-title":"Forensic Sci Int"},{"key":"206_CR19","first-page":"447","volume":"58","author":"M Schulz","year":"2003","unstructured":"Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie. 2003;58:447\u201374.","journal-title":"Pharmazie"},{"key":"206_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/bmb\/ldv017","volume":"114","author":"J Lally","year":"2015","unstructured":"Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114:169\u201379.","journal-title":"Br Med Bull"},{"key":"206_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001861","volume":"12","author":"J Moncrieff","year":"2015","unstructured":"Moncrieff J. Antipsychotic maintenance treatment: time to rethink? PLoS Med. 2015;12:e1001861. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1001861\n                    \n                  .","journal-title":"PLoS Med"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40199-018-0206-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-018-0206-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-018-0206-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T20:40:19Z","timestamp":1569271219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40199-018-0206-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s40199-018-0206-4","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"28 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest. The manuscript entitled: \u201cIn vitro melanogenesis inhibition by fluphenazine and prochlorperazine in normal human melanocytes lightly pigmented\u201d, which all the listed authors have read and approved of, has not been submitted elsewhere for publication, in whole or in part, and is permitted to be published in this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}